Durata Therapeutics, Inc., a biopharmaceutical company, plans to relocate its research and development, clinical, and regulatory operations from New Jersey to Branford, Conn., where it will create up to 80 full-time jobs.
Gov. Dannel P Malloy's Office said as an incentive state economic development will provide the firm with up to $2.25 million in grants. Durata will move into its new quarters at 322 E. Main Street in Branford.
Grants include $2 million of state assistance from the Economic and Community Development, which will be used for leasehold improvements, research and development, furniture, fixtures and equipment, relocation costs, and other project-related expenses. The remaining $250,000 will be provided as a training grant.
"The goal of Bioscience Connecticut is twofold, creating good paying jobs with good benefits for residents in an industry that is poised for growth," said Malloy. "With the addition of Durata Therapeutics, we are further cementing the state as a destination for health and life science companies. Connecticut will continue to cultivate new investment, attract new talent, and work with our entrepreneurs to develop our workforce and strengthen our state's position as a global leader in this rapidly expanding field."
While officials of the firm were not immediately available for comment, State Representative Lonnie Reed said, "We are thrilled to welcome Durata Therapeutics to Branford and are grateful to the Governor for helping the company choose Connecticut. Durata promises to create at least 80 substantial jobs, has huge potential for growth and joins a community of Branford life sciences firms dedicated to curing diseases and saving lives.